New research from investigators at Mass General Brigham suggests that a commonly used type 2 diabetes medication is linked to ...

We spoke with endocrinologists to explore the potential of artificial intelligence in the management of chronic disease, including diabetes, obesity, and PCOS.

Commonly used sulfonylureas were associated with an up to 13% increase in risk for major adverse CV events vs.

New research from investigators at Mass General Brigham suggests that a commonly used type 2 diabetes medication is linked to a higher rate of heart-related conditions compared to medications that hit ...

Sulfonylureas as a whole are already known for their weight gain and hypoglycemia side effects. In practice, glipizide has ...

A commonly used type 2 diabetes medication in the US -- Glipizide -- may be linked to a higher rate of heart-related ...

A widely used diabetes drug, glipizide, may quietly increase heart-related risks, according to a major study. Though ...

What was not known was whether it matters for how long someone has been exposed to excess weight,” said Alexander Turchin, M.D., M.S., Director of Quality at the Division of Endocrinology at ...

Among 122,487 patients with class II obesity or higher (BMI ≥35), 9.1% discussed metabolic and bariatric surgery with their healthcare provider and 12.2% of these progressed to surgery from 2000 ...